News | March 19, 2012

National Physical Laboratory Purchases Nucletron's Brachytherapy Afterloader

March 19, 2012 -- The National Physical Laboratory (NPL), the United Kingdom's national measurement institute, recently purchased a Flexitron afterloader from Nucletron, an Elekta company. NPL will continue to offer its brachytherapy calibration service with the new afterloader and ensure source calibrations in radiotherapy centers remain traceable to NPL's primary standard.

"We chose Flexitron because it is a highly advanced brachytherapy platform that met all our requirements, offering the accuracy necessary to achieve the scientific excellence we strive for," says Thorsten Sander, senior research scientist at NPL. "Flexitron also provides us the opportunity to collaborate in the development of new technologies, to expand brachytherapy products and applications."

Nucletron and NPL have collaborated since 1992.

Flexitron is an advanced afterloader that takes brachytherapy to a new level. With robust safety features and flexible 40-channel configuration, Flexitron is designed to treat both very small and very large tumors without reconnections in intuitive 1 mm steps.

Accurate determination of source positions is simplified and reliability is enhanced with Nucletron's zero reference source positioning system, which defines dwell positions in absolute values. This significantly reduces the chance of human error; no additional measures or manual recalculations are required. Procedures take less time and are easier to check. Flexitron patented source drives are more precise and
durable than ever, providing reliable treatment from year to year.

For more information: www.nucletron.com, www.npl.co.uk/ionising-radiation

Related Content

Xstrahl Photoelectric Therapy System Receives FDA 510(k) Clearance
Technology | Radiation Therapy | October 20, 2017
Xstrahl announced that its Photoelectric Therapy System has received U.S. Food and Drug Administration (FDA) 510(k)...
News | Brachytherapy Systems | October 05, 2017
External researchers presented new clinical data supporting the use of iCAD’s Xoft Axxent Electronic Brachytherapy (eBx...
International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017
Findings from a new multicenter, international clinical trial confirm the effectiveness of high-dose brachytherapy or...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
News | Brachytherapy Systems | July 20, 2017
July 20, 2017 — Rates of recurrence in early-stage non-melanoma skin cancer (NMSC) patients were virtually identical
iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative...
prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...
Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer
News | Brachytherapy Systems | January 16, 2017
On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic...
iCAD, IORT boost, Xoft Axxent Electronic Brachytherapy System, intraoperative radiation therapy, whole breast radiation, early-stage breast cancer, SABCS 2016
News | Brachytherapy Systems | January 05, 2017
iCAD Inc. announced that researchers presented updated data on the use of intraoperative radiation therapy (IORT) with...
Samsung, Neurologica, BodyTom CT scanner, Willis-Knighton Health System, Louisiana, La., brachytherapy, radiation therapy, ASTRO 2016
News | Computed Tomography (CT) | October 27, 2016
Samsung announced in September that the Willis-Knighton Cancer Center in Shreveport, La., added BodyTom CT, the world’s...
Overlay Init